Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.70
-0.20 (-0.74%)
At close: Jan 30, 2026
48.75%
Market Cap21.63B +100.8%
Revenue (ttm)1.78B +42.7%
Net Income268.63M +116.5%
EPS0.44 +21.6%
Shares Out810.02M
PE Ratio61.11
Forward PE50.76
Dividend0.40 (1.51%)
Ex-Dividend DateNov 24, 2025
Volume3,888,328
Average Volume15,568,966
Open27.30
Previous Close26.90
Day's Range26.65 - 27.30
52-Week Range14.65 - 40.10
Betan/a
RSI68.87
Earnings DateApr 22, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd. [Read more]

Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2024, Daiken Biomedical's revenue was 1.36 billion, an increase of 14.45% compared to the previous year's 1.19 billion. Earnings were 106.58 million, a decrease of -33.54%.

Financial Statements